<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="t0010">
 <label>Table 1</label>
 <caption>
  <p>The structure of respiratory syncytial virus and antigenic sites 
   <xref rid="bb0200" ref-type="bibr">[39]</xref>.
  </p>
 </caption>
 <alt-text id="al0015">Table 1</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th colspan="2">RSV structure and protein function</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Non Structural Proteins
     <break/> NS1 and NS2
     <break/> M2-2
    </td>
    <td>
     <break/>Counteract interferon responses
    </td>
   </tr>
   <tr>
    <td>Internal Structural Proteins
     <break/> N, P, M, M2-1, L
    </td>
    <td/>
   </tr>
   <tr>
    <td>Surface Structural Proteins
     <break/> Fusion (F)
     <break/> Attachment (G)
     <break/> Small hydrophobic (SH)
    </td>
    <td>
     <break/>F – determines viral entry to host cells
     <break/>G – determines binding to host cells
     <break/>F and G proteins have the antigenic determinants that elicit neutralizing antibodies to RSV
    </td>
   </tr>
   <tr>
    <td colspan="2">
     <bold>Main antigenic sites of RSV F-protein listed by order of ability to elicit neutralizing antibodies</bold>
    </td>
   </tr>
   <tr>
    <td>Site Φ
     <break/>Site V
    </td>
    <td>Sites Φ and V are pre-F specific epitopes, present at the apex of the pre-F protein and therefore highly neutralizing sensitive. Antibodies to these sites have the highest neutralizing potency</td>
   </tr>
   <tr>
    <td>Site III
     <break/>Site IV
     <break/>Site II
    </td>
    <td>Sites III, IV and II are present in both pre-F and post-F conformation. Palivizumab binds to site II.</td>
   </tr>
   <tr>
    <td>Site I</td>
    <td>Site I is mostly present in post-F conformation</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
